Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 2
1948 4
1949 7
1950 5
1951 1
1952 3
1953 7
1954 4
1955 3
1956 8
1957 8
1958 5
1959 7
1960 4
1961 1
1962 4
1963 10
1964 30
1965 13
1966 17
1967 24
1968 29
1969 27
1970 30
1971 39
1972 35
1973 58
1974 68
1975 53
1976 46
1977 65
1978 62
1979 67
1980 95
1981 77
1982 66
1983 87
1984 92
1985 94
1986 100
1987 107
1988 112
1989 110
1990 115
1991 121
1992 150
1993 160
1994 177
1995 177
1996 182
1997 241
1998 208
1999 243
2000 258
2001 251
2002 277
2003 402
2004 402
2005 391
2006 429
2007 472
2008 454
2009 505
2010 566
2011 677
2012 698
2013 702
2014 807
2015 733
2016 741
2017 776
2018 822
2019 813
2020 874
2021 884
2022 796
2023 756
2024 273

Text availability

Article attribute

Article type

Publication date

Search Results

16,463 results

Results by year

Filters applied: . Clear all
Page 1
Prostate cancer and bone: clinical presentation and molecular mechanisms.
Wells KV, Krackeler ML, Jathal MK, Parikh M, Ghosh PM, Leach JK, Genetos DC. Wells KV, et al. Endocr Relat Cancer. 2023 Jul 25;30(9):e220360. doi: 10.1530/ERC-22-0360. Print 2023 Sep 1. Endocr Relat Cancer. 2023. PMID: 37226936 Free PMC article. Review.
Prostate cancer (PCa) is an increasingly prevalent health problem in the developed world. ...Skeletally metastatic PCa is difficult to investigate due to the entwined nature of bone biology and cancer biology. Herein, we survey PCa from origin, present …
Prostate cancer (PCa) is an increasingly prevalent health problem in the developed world. ...Skeletally metastatic PCa is diff …
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer.
Zhang X. Zhang X. Cancer Commun (Lond). 2019 Nov 21;39(1):76. doi: 10.1186/s40880-019-0425-1. Cancer Commun (Lond). 2019. PMID: 31753020 Free PMC article. Review.
Here, we explained the mechanism of interactions between prostate cancer cells and metastasis-associated cells within the bone microenvironment and further discussed the recent advances in targeted therapy of prostate cancer bone metastas …
Here, we explained the mechanism of interactions between prostate cancer cells and metastasis-associated cells within the b …
The Bone Microenvironment in Prostate Cancer Metastasis.
DiNatale A, Fatatis A. DiNatale A, et al. Adv Exp Med Biol. 2019;1210:171-184. doi: 10.1007/978-3-030-32656-2_9. Adv Exp Med Biol. 2019. PMID: 31900910 Review.
The propensity of prostate cancer cells to seed the skeleton and then progress into clinically relevant metastatic tumors is widely recognized and a major cause of morbidity and mortality for patients. ...While generalization in clinical practice is always unwise, i …
The propensity of prostate cancer cells to seed the skeleton and then progress into clinically relevant metastatic tumors is w …
Bone-targeted therapy in castration-resistant prostate cancer: where do we stand?
Gómez Rivas J, Carrion DM, Alvarez-Maestro M, Cathelineau X, Sanchez-Salas R, Di Lorenzo G, Di Maio M, Paul A, Martinez-Piñeiro L, Sartor O, Saad F, Debruyne F. Gómez Rivas J, et al. Minerva Urol Nefrol. 2019 Oct;71(5):445-456. doi: 10.23736/S0393-2249.19.03420-9. Epub 2019 Jul 25. Minerva Urol Nefrol. 2019. PMID: 31353876 Free article. Review.
INTRODUCTION: In the last years, there have been significant developments in the therapeutic armamentarium of metastatic castration-resistant prostate cancer (mCRPC). New evidence shows that the addition of bone-targeted agents (BTA) to "life-prolonging agent …
INTRODUCTION: In the last years, there have been significant developments in the therapeutic armamentarium of metastatic castration-resistan …
Bone-targeting agents in prostate cancer.
Suzman DL, Boikos SA, Carducci MA. Suzman DL, et al. Cancer Metastasis Rev. 2014 Sep;33(2-3):619-28. doi: 10.1007/s10555-013-9480-2. Cancer Metastasis Rev. 2014. PMID: 24398856 Free PMC article. Review.
Bone metastases are present in the vast majority of men with advanced prostate cancer, representing the main cause for morbidity and mortality. ...This review summarizes agents that target the pathways involved in this complex interaction between prostate …
Bone metastases are present in the vast majority of men with advanced prostate cancer, representing the main cause for …
Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion.
Santini D, Berruti A, Di Maio M, Procopio G, Bracarda S, Ibrahim T, Bertoldo F. Santini D, et al. ESMO Open. 2020 Mar;5(2):e000652. doi: 10.1136/esmoopen-2019-000652. ESMO Open. 2020. PMID: 32220946 Free PMC article. Review.
Bone health impairment is a frequent detrimental consequence of the high bone tropism of prostate cancer (PCa) cells. ...Finally, the expert opinion to optimise bone health preservation is given....
Bone health impairment is a frequent detrimental consequence of the high bone tropism of prostate cancer (PCa) c …
Prostate cancer and bone: the elective affinities.
Rucci N, Angelucci A. Rucci N, et al. Biomed Res Int. 2014;2014:167035. doi: 10.1155/2014/167035. Epub 2014 May 28. Biomed Res Int. 2014. PMID: 24971315 Free PMC article. Review.
Bone is a common site of metastases in few types of cancer, and it represents the most frequent metastatic site in prostate cancer. ...As anticipated by the success of current targeted therapy aimed to block bone resorption, a better understandi …
Bone is a common site of metastases in few types of cancer, and it represents the most frequent metastatic site in prostate …
Bone targeted therapies in metastatic castration-resistant prostate cancer.
Rajpar S, Fizazi K. Rajpar S, et al. Cancer J. 2013 Jan-Feb;19(1):66-70. doi: 10.1097/PPO.0b013e31827f123e. Cancer J. 2013. PMID: 23337759 Review.
Prostate cancer is the most common male cancer. About 90% of metastatic patients will develop bone metastases. ...Proliferation of prostate cancer cells in the bone marrow induces osteoclast activation and osteolysis. ...
Prostate cancer is the most common male cancer. About 90% of metastatic patients will develop bone metastases. . …
Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer.
Lee CH, Decker AM, Cackowski FC, Taichman RS. Lee CH, et al. Cell Biol Toxicol. 2020 Apr;36(2):115-130. doi: 10.1007/s10565-019-09483-7. Epub 2019 Jun 27. Cell Biol Toxicol. 2020. PMID: 31250347 Free PMC article. Review.
Prostate cancer (PCa) is one of the most prevalent cancers and the second leading cause of cancer death among US males. ...Unfortunately, the treatment efficacy of each approach decreases significantly in later stages of PCa that involve metastasis to soft ti …
Prostate cancer (PCa) is one of the most prevalent cancers and the second leading cause of cancer death among US males. …
Bone imaging in prostate cancer.
Dotan ZA. Dotan ZA. Nat Clin Pract Urol. 2008 Aug;5(8):434-44. doi: 10.1038/ncpuro1190. Nat Clin Pract Urol. 2008. PMID: 18682719 Review.
Bone metastases of solid tumors are common, and about 80% of them occur in patients with breast, lung or prostate cancer. ...Bone metastases of prostate cancer usually have osteoblastic characteristics, manifested by pathological bone …
Bone metastases of solid tumors are common, and about 80% of them occur in patients with breast, lung or prostate cancer …
16,463 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "prostate cancer bone"